| Name | Title | Contact Details |
|---|
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Associated Billing Services is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OPCO Laboratory Inc is a Fitchburg, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Maxim Healthcare Services is a healthcare staffing agency that provides recruitment, training, and management of a diverse healthcare workforce for their clients.
VASA is passionate about fitness and changing lives! We currently have 31 locations and recently expanded from our home state, Utah, to Colorado and the Midwest. With over 200K members and nearly 2,000 employees, our VASA fam just keeps growing!